Artwork

Content provided by American Academy of Ophthalmology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Academy of Ophthalmology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ocular Oncology Clinical Trial Update

31:13
 
Share
 

Manage episode 435663931 series 2997867
Content provided by American Academy of Ophthalmology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Academy of Ophthalmology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Drs. Maura Di Nicola and Basil Williams join host Dr. Jay Sridhar to discuss the latest ongoing ocular oncology clinical trials for the treatment of uveal melanoma and associated complications of radiation therapy.

Their review begins with the DRCR Retina Network’s Protocol AL, which is studying the use of anti-VEGF agents or corticosteroids to reduce the occurrence of radiation retinopathy and consequent vision loss. Drs. Di Nicola and Williams also offer insights about the use of Belzupacap Sarotalocan (Bel-sar) for early-stage choroidal melanoma (CoMpass trial), as well as adjuvant treatment with darovasertib, a protein kinase C inhibitor.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

  continue reading

75 episodes

Artwork
iconShare
 
Manage episode 435663931 series 2997867
Content provided by American Academy of Ophthalmology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by American Academy of Ophthalmology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

Drs. Maura Di Nicola and Basil Williams join host Dr. Jay Sridhar to discuss the latest ongoing ocular oncology clinical trials for the treatment of uveal melanoma and associated complications of radiation therapy.

Their review begins with the DRCR Retina Network’s Protocol AL, which is studying the use of anti-VEGF agents or corticosteroids to reduce the occurrence of radiation retinopathy and consequent vision loss. Drs. Di Nicola and Williams also offer insights about the use of Belzupacap Sarotalocan (Bel-sar) for early-stage choroidal melanoma (CoMpass trial), as well as adjuvant treatment with darovasertib, a protein kinase C inhibitor.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

  continue reading

75 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide